New meta-analysis reviews safety and efficacy of Epidiolex® near pure cannabidiol (CBD) in difficult to treat epilepsy

2018-11-07T20:22:35+00:00

New meta-analysis reviews safety and efficacy of Epidiolex® near pure cannabidiol (CBD) in difficult to treat epilepsy

Date of publication: November 3, 2018

Top line takeaways

Study design: Meta-analysis

Databases searched: Medline, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov

Number of studies included in analysis: Four

Number of patients: 550 subjects (Intention To Treat [ITT] analysis): 323 for […]